Goodbody Health Limited
GDBYF · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,886 | $2,235 | $5,169 | $7,183 |
| % Growth | -15.6% | -56.8% | -28% | – |
| Cost of Goods Sold | $1,039 | $1,220 | $2,565 | $3,555 |
| Gross Profit | $847 | $1,015 | $2,604 | $3,628 |
| % Margin | 44.9% | 45.4% | 50.4% | 50.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $992 | $1,185 | $1,205 | $1,409 |
| SG&A Expenses | $1,692 | $1,813 | $2,145 | $3,102 |
| Sales & Mktg Exp. | $700 | $628 | $939 | $1,693 |
| Other Operating Expenses | -$845 | -$798 | $0 | $526 |
| Operating Expenses | $847 | $1,015 | $2,604 | $3,602 |
| Operating Income | -$983 | -$1,018 | $90 | $27 |
| % Margin | -52.1% | -45.5% | 1.7% | 0.4% |
| Other Income/Exp. Net | -$283 | -$208 | -$275 | -$1,005 |
| Pre-Tax Income | -$1,266 | -$1,227 | -$185 | -$978 |
| Tax Expense | $0 | -$81 | $81 | $68 |
| Net Income | -$1,266 | -$1,146 | -$266 | -$1,046 |
| % Margin | -67.1% | -51.3% | -5.1% | -14.6% |
| EPS | -0.035 | -0.031 | -0.007 | 0 |
| % Growth | -10.5% | -330.1% | – | – |
| EPS Diluted | -0.035 | -0.031 | -0.007 | 0 |
| Weighted Avg Shares Out | 36,496 | 36,496 | 36,496 | 0 |
| Weighted Avg Shares Out Dil | 36,496 | 36,496 | 36,496 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $0 | $0 | $0 |
| Interest Expense | $1 | $2 | $2 | $3 |
| Depreciation & Amortization | $141 | $137 | $128 | $256 |
| EBITDA | -$842 | -$881 | $218 | $282 |
| % Margin | -44.6% | -39.4% | 4.2% | 3.9% |